Table 2.
Baseline Characteristics of Patients With AF, According to First Prescribed OAC After Propensity Score Matching: Optum, 2010–2015
| Characteristics | Comparison of DOACs With Warfarin | Comparison Among Dabigatran, Rivaroxaban, and Apixaban | ||
|---|---|---|---|---|
| Warfarin | Dabigatran | Dabigatran | Rivaroxaban | |
| N | 15 179 | 15 179 | 10 178 | 10 178 |
| Age, mean (SD), y | 69 (12) | 69 (12) | 69 (12) | 69 (12) |
| Women, % | 37 | 37 | 37 | 37 |
| Race, % white | 79 | 79 | 78 | 78 |
| CHA2DS2‐VASc score, mean (SD) | 3.6 (2.0) | 3.6 (2.0) | 3.7 (2.0) | 3.7 (2.1) |
| HAS‐BLED score, mean (SD) | 2.3 (1.3) | 2.3 (1.3) | 2.3 (1.3) | 2.3 (1.3) |
| Warfarin | Rivaroxaban | Dabigatran | Apixaban | |
| N | 22 439 | 22 439 | 4757 | 4757 |
| Age, mean (SD), y | 71 (11) | 70 (12) | 70 (11) | 70 (12) |
| Women, % | 40 | 40 | 38 | 38 |
| Race, % white | 77 | 78 | 76 | 76 |
| CHA2DS2‐VASc score, mean (SD) | 3.8 (2.0) | 3.8 (2.1) | 3.8 (2.0) | 3.8 (2.1) |
| HAS‐BLED score, mean (SD) | 2.5 (1.3) | 2.5 (1.3) | 2.4 (1.3) | 2.4 (1.3) |
| Warfarin | Apixaban | Rivaroxaban | Apixaban | |
| N | 11 784 | 11 784 | 11 785 | 11 785 |
| Age, mean (SD), y | 73 (10) | 73 (11) | 72 (11) | 73 (11) |
| Women, % | 45 | 45 | 45 | 45 |
| Race, % white | 77 | 77 | 77 | 77 |
| CHA2DS2‐VASc score, mean (SD) | 4.3 (2.0) | 4.2 (2.1) | 4.2 (2.1) | 4.2 (2.1) |
| HAS‐BLED score, mean (SD) | 2.7 (1.3) | 2.7 (1.3) | 2.7 (1.3) | 2.7 (1.3) |
Comparison groups are matched 1:1. AF indicates atrial fibrillation; DOAC, direct oral anticoagulant.